FindTrial
Sign In

Study on Risk Factors of Medication Harm and Its Predictive Value for Unplanned Readmission in Elderly Patients with Multiple Comorbidities and Polypharmacy during the Discharge Transition Period

Study on Risk Factors of Medication Harm and Its Predictive Value for Unplanned Readmission in Elderly Patients with Multiple Comorbidities and Polypharmacy during the Discharge Transition Period

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117936
Enrollment
Unknown
Registered
2026-01-30
Start date
2025-04-13
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic diseases in the elderly

Interventions

Control group:None
Observation group:None

Sponsors

Taizhou Municipal People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 65 years old. 2.Patients diagnosed by a physician with three or more chronic diseases, with a duration of at least 1 year for each diagnosis. 3.Taking five or more types of medications. 4.Patients who are living at home after hospital discharge. 5.Have provided informed consent and are willing to participate in this study voluntarily.

Exclusion criteria

Exclusion criteria: 1.Combined speech and hearing impairments; 2.Patients with severe cognitive impairments; 3.Participants in other medication-related studies; 4.Terminally ill patients (expected survival time less than 3 months).

Design outcomes

Primary

MeasureTime frame
Frailty severity;Sleep quality;Alexithymia;—

Countries

China

Contacts

Public ContactRuihong Liu

Taizhou Municipal People's Hospital

54735488@qq.com+86 139 1219 7500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026